New Data Demonstrate Aimovig™ (erenumab) Reduced Monthly Migraine Days In Patients Who Failed Previous Preventive Therapies

Go back to New Data Demonstrate Aimovig™ (erenumab) Reduced Monthly Migraine Days In Patients Who Failed Previous Preventive Therapies
Amgen Inc (NASDAQ: AMGN) Delayed: 401.00 -36.23 (8.29%)
Previous Close $437.23    52 Week High $176.85 
Open $408.90    52 Week Low $133.64 
Day High $410.03    P/E 60.39 
Day Low $399.68    EPS $6.64 
Volume 1,157,205